Navigation Links
Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
Date:6/12/2012

SAN DIEGO, June 12, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

Last week, Medical News Today reported on a cancer research discovery that reinforces the potential importance of our therapeutic endeavors.  For more than a century, cancer researchers have understood that certain forms of cancer only spread to specific, preferred organs. However, the mechanism underlying the spread of organ specific metastasis (the "soil and seed" theory of 1889) had remained unknown. Based on new findings published and now available online in the journal Nature, researchers have identified that circulating cancer-secreted particles known as "exosomes" play a significant role in fueling the metastatic invasion of preferred organs.  The paper concludes that exosomes offer promise for new therapeutic directions in the metastatic process.

We applaud and appreciate this ground breaking research as our Hemopurifier® has been validated to capture the form of cancer-secreted exosomes referenced in the publication. The same Hemopurifier® that we have been advancing with promising results in the treatment of hepatitis c (HCV) infected individuals.

In the study, researchers were interested to see if exosomes budding from melanoma actually participated in the course of the cancer. The answer was yes, and to a great extent. The researchers identified that melanoma cancer cells released "exosome" vesicles (microscopic particles like "bubbles" that are filled with many different molecules such as proteins and nucleic acids) that travel to the bone, liver, lung and brain. This cellular material fuses with targeted organs and establishes the environment to spread tumor cells.  The researchers also reported that
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
2. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
3. Aethlon Medical Note: Fiscal Year Revenue Guidance
4. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
5. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
6. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
7. Medical Device Developers - Network at BIOMEDevice Boston Next Week
8. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
9. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
10. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
11. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Cadence Fitness & Health Center ... by the Medical Fitness Association, a non-profit organization ... achieve their full potential. The Cadence Fitness & ... in the western suburbs and second in the ... Cadence Fitness & Health Center meets guidelines set ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... – Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Analysis Insulin Pumps ... as insulin delivery systems especially for type ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ... $2.92 per share, net to the seller in cash, ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... , , , COLUMBIA, S.C. ... home pilot project that could become a model for South Carolina ... also attracting the attention of S.C. physicians not involved in the ... to managing their health care costs. , , ...
... , ANN ARBOR, Mich., July 24 Terumo ... Phase II Clinical Trial for the Anaconda(TM) AAA (Abdominal Aortic ... system is manufactured by Scotland-based Terumo subsidiary Vascutek Ltd. ... at Arizona Heart Hospital by the principal investigator, Julio Rodriguez-Lopez, ...
Cached Medicine Technology:S.C. Medical Home Pilot for Diabetes Enrolls 1,110 2S.C. Medical Home Pilot for Diabetes Enrolls 1,110 3Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System 2
(Date:4/14/2014)... North Therapeutics, Inc., announced today a publication demonstrating ... of human red blood cells exposed to plasma ... hemolytic anemia (AIHA). The article entitled "TNT003, an ... activation induced by cold agglutinin disease patient autoantibodies" ... earlier this month. TNT003 is the murine ...
(Date:4/14/2014)... April 14In dense, urban centers around the world, many ... surrounded by tall buildings that block sunlight. And as ... jammed closer together, the darkness will only spread. ... a corrugated, translucent panel that redirects sunlight onto narrow ... and hung over the edge at an angle, where ...
(Date:4/14/2014)... professor of chemical engineering at Virginia Tech , ... analyze living cells. The long-term goal is to gain ... In his lab , Lu and his students ... events inside cells. These devices promote high sensitivity and ... cells. , Based on their record of achievements, the ...
(Date:4/14/2014)... April 2014, Perth, Australia. Drug discovery company Proteomics ... development of a companion diagnostic (CDx) test with ... , The research team authenticated the panel of ... control samples. Seven biomarkers were validated at high ... , The mass spectrometry data was then cross-validated ...
(Date:4/14/2014)... guidelines for high-risk bladder cancer, chemotherapy before or ... clinical practice. The findings are published early online ... the American Cancer Society. , Clinical trials have ... muscle-invasive bladder cancer who are given chemotherapy before ... after surgery also improves survival. To investigate the ...
Breaking Medicine News(10 mins):Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
... medication to treat kleptomania has failed to find any ... according to researchers at the Stanford University School of ... that some medications, including the one in the trial, ... ,More than 1.2 million people in the ...
... of acute lymphoblastic leukemia have a significantly increased risk ... // ,Acute lymphoblastic leukemia is the most common ... cases diagnosed in the United States each year. It ... survival rates for patients who receive contemporary treatments now ...
... pathway by which estradiol, the primary estrogen in humans ... aids in avoiding osteoporosis. // ,It is well ... that when the production of estrogen is reduced, as ... to radiation or chemotherapeutic drugs, bones become brittle and ...
... college students, could be as harmful as cigarettes, warns a ... water in a hookah, many youngsters feel that harmful agents ... have been found between water-pipe (hookah) usage and oral, lung ... arteries," it said quoting a report of the American Lung ...
... percentage of South Asians registered in the US National Marrow ... perforce join a long queue for matching donors. ... matching bone marrow transplant here. ,Urmi, 5, has ... transplant. She loves to play with her dolls and read ...
... cancer still remains the best way to ... During the 85th General Session of the International Association ... presented two novel, non-invasive, ultra-fast images approaches to oral ... than half of all oral cancer cases documented ...
Cached Medicine News:Health News:Study Finds No Conclusive Benefit from Treating Kleptomania 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Estradiol Guards Against Osteoporosis 2Health News:Novel Methods in Diagnosing Oral Cancer 2
... Reichert UNISTAT Bilirubinometer is ... for determining total bilirubin ... It quickly determines if ... needed by providing measurement ...
Anti-GBM IgG Assay...
... EIA Test is based on ... phase enzyme-linked immunosorbent assay. The ... anti-FSH for solid phase (microtiter ... FSH in the antibody-enzyme (horseradish ...
Enzyme immunoassay for the quantitative determination of IgG autoantibodies against type IV collagen of glomerular or alveolar basement membrane (GBM) in serum and plasma....
Medicine Products: